Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1370 participants.

Also called NCT02160145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,370 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02160145
Other papers using this trial's data
  • Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease The New England journal of medicine, 2017-11-16 DOI, PubMed 29105594

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Australia, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Puerto Rico, Romania, Russia, South Africa, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02160145. Randomized; quadruple masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2017-04-18 (actual). Results posted on 2018-08-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Condition
Autosomal Dominant Polycystic Kidney Disease
Intervention (Drug)
Tolvaptan (OPC-41061)
Intervention (Drug)
Placebo
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02160145
Content hash
0ce2e540e9585a4ddc6ebb304940e3b16fea91a0381b1f275ee4aeaa1ba51980